Literature DB >> 23043846

The excess burden of rheumatoid arthritis in Ontario, Canada.

Jean-Eric Tarride1, Mahbubul Haq, Hamid R Nakhai-Pour, Daria J O'Reilly, Feng Xie, Lisa Dolovich, Gord Blackhouse, Ron Goeree.   

Abstract

OBJECTIVES: The purpose of this study was to estimate the excess burden of RA in Ontario, the largest province in Canada.
METHODS: The records of all adult Ontarians who participated in the Canadian Community Health Survey (CCHS) cycle 1.1 (2000/2001) and provided consent to data linkage were linked to the Ontario Health Insurance Program (OHIP) physician claims database and the Discharge Abstract Database (DAD) In-Patient (i.e. hospitalisation) and Day-Procedure databases. RA individuals (n=233) were identified using CCHS 1.1 and the physician claims database. A control group matched by age, gender and rural/urban status was created with three controls for one case (n=699). Socio-demographic variables, medical characteristics, health-related quality of life (HRQoL) and one-year physician services, hospitalizations and day procedures costs were determined for the RA and non-RA groups. Regression techniques were used to identify predictors of medical characteristics, utility and cost data.
RESULTS: The mean age of the population was 59 years and 76% were female. Compared to the matched control group, individuals with RA were statistically more likely to be obese, less educated, physically inactive and have a lower income. RA individuals also reported a statistically higher number of comorbidities and a lower HRQoL. Although no statistical differences were observed between the RA and non-RA groups for the costs associated with hospitalisations, the physician ($1,015 vs. $624, respectively) and day procedure ($102 vs. $51, respectively) costs were statistically higher among RA individuals.
CONCLUSIONS: These results indicate that the human and economic burden of RA in Ontario is considerable.

Entities:  

Mesh:

Year:  2012        PMID: 23043846

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial.

Authors:  Min Yang; Ming-Yang Guo; Yong Luo; Ming-Dong Yun; Jiao Yan; Tao Liu; Chang-Hong Xiao
Journal:  Chin J Integr Med       Date:  2016-12-29       Impact factor: 1.978

2.  Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review.

Authors:  Anaïs Lacasse; Elizabeth Cauvier Charest; Roxanne Dault; Anne-Marie Cloutier; Manon Choinière; Lucie Blais; Alain Vanasse
Journal:  Pain Med       Date:  2020-09-01       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.